25
Jul

In a deal that will build on their existing mutual relationship, Bristol-Myers Squibb and Ono Pharmaceutical have formed a pact to bring immunotherapies to market in Japan, South Korea and Taiwan.

…read more

Source: Bristol-Myers inks Asia immunotherapy deal with Japan’s Ono

    

0 No comments